Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioventus (BVS) Tax Provisions (2020 - 2026)

Bioventus filings provide 6 years of Tax Provisions readings, the most recent being -$3.2 million for Q4 2025.

  • On a quarterly basis, Tax Provisions fell 677.27% to -$3.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.6 million, a 70.43% increase, with the full-year FY2025 number at -$1.6 million, up 70.43% from a year prior.
  • Tax Provisions hit -$3.2 million in Q4 2025 for Bioventus, down from $664000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $1.7 million in Q3 2021 to a low of -$29.5 million in Q4 2022.
  • Median Tax Provisions over the past 5 years was -$84000.0 (2021), compared with a mean of -$2.7 million.
  • Biggest five-year swings in Tax Provisions: soared 1658.18% in 2021 and later tumbled 6930.14% in 2022.
  • Bioventus' Tax Provisions stood at -$2.7 million in 2021, then tumbled by 302.31% to -$11.0 million in 2022, then surged by 93.16% to -$750000.0 in 2023, then skyrocketed by 173.33% to $550000.0 in 2024, then crashed by 677.27% to -$3.2 million in 2025.
  • The last three reported values for Tax Provisions were -$3.2 million (Q4 2025), $664000.0 (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.